Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00275145 · ClinicalTrials.gov registry record · Phase 2

Effects of Resistance and Aerobic Exercise on Cardiovascular Health

A Phase 2 study of Obesity and Cardiovascular Diseases, sponsored by Duke University.

Completed
Registry status
Phase 2
Development phase
261
Enrollment target
1
Study location

NCT00275145 is a Phase 2 study of Obesity and Cardiovascular Diseases that has completed, run by Duke University. The registered enrollment target is 261 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (68% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00275145, a Phase 2 study of Obesity and Cardiovascular Diseases, has completed, sponsored by Duke University.

COMPLETED
Registry status
Phase 2
Development phase
261 participants
Enrollment target
1
Study location

Study Summary

This study will investigate the separate and combined effects of aerobic and resistance training on cardiovascular risk factors in overweight men and women with mild to moderate dyslipidemia.

Interventions

  • BEHAVIORAL Resistance Training
  • BEHAVIORAL Aerobic Exercise
  • BEHAVIORAL Combo
  • BEHAVIORAL Continued Sedentary lifestyle

Study Locations (1)

North Carolina

  • Duke University - Durham

Trial Details

FieldValue
Enrollment Target 261 participants
Start Date 2004-05
Est. Completion 2008-12
Phase Phase 2

Sponsor

Duke University

1,725 total trials

What the Registry Record Tells You About NCT00275145

The ClinicalTrials.gov registry entry for NCT00275145 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 261 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (68% lower). The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.

The record links to 6 conditions, with Obesity appearing as the primary indexed condition, and to 4 interventions - of which Resistance Training is the first listed.

NCT00275145 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.

Frequently Asked Questions

What is clinical trial NCT00275145 about?

NCT00275145 is a clinical study titled "Effects of Resistance and Aerobic Exercise on Cardiovascular Health". This study will investigate the separate and combined effects of aerobic and resistance training on cardiovascular risk factors in overweight men and women with mild to moderate dyslipidemia.

What is the current status of trial NCT00275145?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 261 participants. The study started on 2004-05. Estimated completion is 2008-12.

What conditions does trial NCT00275145 study?

This clinical trial studies the following conditions: Obesity, Cardiovascular Diseases, Insulin Resistance, Heart Diseases, Hyperlipidemia.

What interventions are being tested in trial NCT00275145?

The interventions under investigation include: Resistance Training (BEHAVIORAL), Aerobic Exercise (BEHAVIORAL), Combo (BEHAVIORAL), Continued Sedentary lifestyle (BEHAVIORAL).

Who is sponsoring clinical trial NCT00275145?

This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00275145 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.